RxSight officer exercises 35,168 stock options

RxSight’s chief business development officer exercised 35,168 options, lifting his direct holdings while also reporting substantial trust and spousal indirect ownership.

Rhea-AI Filing Summary

RxSight, Inc. (RXST) reported that Chief Business Development Officer Eric Weinberg exercised stock options for 35,168 shares of common stock on September 15, 2026 at an exercise price of $4.34 per share, increasing his directly held common stock to 235,516 shares.

He also is reported as having indirect ownership of 299,978 shares of common stock through the EJW Living Trust, where he serves as trustee, and 925 shares held by his spouse. The options exercised were fully vested and exercisable, and no Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

35,168 shares exercised/converted

Exercise 4 txns

Insider Weinberg Eric

Role See remarks

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy) F2	35,168	$0.00	$0.00
Exercise	Common Stock	35,168	$4.34	$153K
holding	Common Stock F1	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 235,516 shares (Direct); Common Stock — 299,978 shares (Indirect, See footnote); Common Stock — 925 shares (Indirect, By spouse)

Footnotes (2)

1. F1. Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee.
2. F2. The shares subject to the option were fully vested and exercisable.

Key Figures

Options exercised: 35,168 shares Exercise price: $4.34 per share Direct common shares after exercise: 235,516 shares +3 more

6 metrics

Options exercised 35,168 shares Stock options converted into common stock on September 15, 2026

Exercise price $4.34 per share Exercise price for 35,168 options into common stock

Direct common shares after exercise 235,516 shares Directly held RxSight common stock following the September 15, 2026 transactions

Indirect trust holdings 299,978 shares Common stock held by the EJW Living Trust with Eric Weinberg as trustee

Indirect spouse holdings 925 shares Common stock reported as held indirectly through spouse

Option expiration date March 14, 2027 Expiration date of the exercised stock option grant

Key Terms

Stock Option (right to buy), Common Stock, Rule 10b5-1 trading plan, fully vested and exercisable, +1 more

5 terms

Stock Option (right to buy) financial

"security titled Stock Option (right to buy) was exercised into common stock"

Common Stock financial

"shares of Common Stock are reported as directly and indirectly owned"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Rule 10b5-1 trading plan regulatory

"no Rule 10b5-1 trading plan is reported for these transactions"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

fully vested and exercisable financial

"the shares subject to the option were fully vested and exercisable"

indirect ownership financial

"indirect ownership is reported through a trust and through a spouse"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RXST insider Eric Weinberg report on this Form 4?

He reported exercising 35,168 stock options for RxSight, Inc. common stock on September 15, 2026 at an exercise price of $4.34 per share, resulting in 235,516 directly held shares of common stock afterward.

How many RxSight (RXST) shares does Eric Weinberg now hold directly?

After the reported option exercise, Eric Weinberg directly holds 235,516 shares of RxSight, Inc. common stock as of September 15, 2026, according to the Form 4 disclosure.

What indirect ownership in RXST does Eric Weinberg report?

He reports indirect ownership of 299,978 shares of RxSight common stock held by the EJW Living Trust, for which he serves as trustee, and an additional 925 shares held indirectly through his spouse.

Were the options exercised by the RXST officer vested?

Yes. A footnote states that the 35,168 shares subject to the stock option were fully vested and exercisable at the time of the exercise reported on September 15, 2026.

Was a Rule 10b5-1 plan used for Eric Weinberg’s RXST transactions?

No. The Form 4 indicates that the transactions reported for Eric Weinberg were not made under a Rule 10b5-1 trading plan, as the related checkbox is not marked.

What price was paid per share in the RXST option exercise?

The stock options were exercised for 35,168 shares of RxSight common stock at an exercise price of $4.34 per share, as disclosed in the Form 4 data for the September 15, 2026 transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:26 PM Accepted by SEC EDGAR 09/16/2026 - 04:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weinberg Eric

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2026		M		35,168	A	$4.34	235,516	D
Common Stock								299,978	I	See footnote(1)
Common Stock								925	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$4.34	09/15/2026		M			35,168	(2)	03/14/2027	Common Stock	35,168	$0	0	D

Explanation of Responses:

1. Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee.

2. The shares subject to the option were fully vested and exercisable.

Remarks:

Chief Business Development Officer

	/s/ Jim Schindler, as Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)